Pressure BioSciences to Receive $500,000 Investment from Ironridge BioPharma | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences announced today an investment agreement with Ironridge BioPharma for $500,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.